Neurodegeneration and Neuroprotection in Multiple Sclerosis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|29|4471-4474

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.29, 2012-10, pp. : 4471-4474

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neurodegeneration in multiple sclerosis

By  

PHARMAKON, Vol. 2, Iss. 6, 2014-11 ,pp. : 388-394

Govi-Verlag

Access to resources Recommend Favorite

Immunomodulation in multiple sclerosis: from immunosuppression to neuroprotection

By Neuhaus O.   Archelos J.J.   Hartung H.-P.  

Trends in Pharmacological Sciences, Vol. 24, Iss. 3, 2003-03 ,pp. : 131-138

Elsevier

Access to resources Recommend Favorite

Optical Coherence Tomography Detection of Neurodegeneration in Multiple Sclerosis

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 5, 2012-08 ,pp. : 518-527

Bentham Science Publishers

Access to resources Recommend Favorite

Neuroinflammation and Neuroprotection: An Update on (Future) Neurotrophin-Related Strategies in Multiple Sclerosis Treatment

By  

Current Medicinal Chemistry, Vol. 18, Iss. 12, 2011-04 ,pp. : 1775-1784

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Strategies To Prevent Neurodegeneration And Promote Regeneration In Multiple Sclerosis

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 5, Iss. 1, 2005-01 ,pp. : 11-26

Bentham Science Publishers

Access to resources Recommend Favorite